A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group ...
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and adults. It is characterized by failures in the maturation of T-lymphocytes, ...
MedPage Today on MSN
Orca-T approved to prevent GVHD after stem cell transplant for blood cancers
Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs ...
Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...
Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...
A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new ...
Despite major advances in immunotherapy—including the 2025 Nobel Prize in Physiology or Medicine recognizing advances in peripheral immune tolerance—progress against leukemia has remained limited.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results